rs72671125

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001365999.1(SZT2):​c.6888C>T​(p.Cys2296Cys) variant causes a synonymous change. The variant allele was found at a frequency of 0.0233 in 1,613,892 control chromosomes in the GnomAD database, including 507 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 39 hom., cov: 33)
Exomes 𝑓: 0.024 ( 468 hom. )

Consequence

SZT2
NM_001365999.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.48

Publications

7 publications found
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
SZT2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-43439615-C-T is Benign according to our data. Variant chr1-43439615-C-T is described in ClinVar as Benign. ClinVar VariationId is 241036.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0193 (2939/152330) while in subpopulation NFE AF = 0.0277 (1884/68012). AF 95% confidence interval is 0.0267. There are 39 homozygotes in GnomAd4. There are 1461 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 39 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SZT2NM_001365999.1 linkc.6888C>T p.Cys2296Cys synonymous_variant Exon 50 of 72 ENST00000634258.3 NP_001352928.1
SZT2NM_015284.4 linkc.6717C>T p.Cys2239Cys synonymous_variant Exon 49 of 71 NP_056099.3 Q5T011-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SZT2ENST00000634258.3 linkc.6888C>T p.Cys2296Cys synonymous_variant Exon 50 of 72 5 NM_001365999.1 ENSP00000489255.1 Q5T011-1

Frequencies

GnomAD3 genomes
AF:
0.0193
AC:
2940
AN:
152212
Hom.:
39
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00458
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0205
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00558
Gnomad FIN
AF:
0.0417
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0277
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.0203
AC:
5086
AN:
250364
AF XY:
0.0206
show subpopulations
Gnomad AFR exome
AF:
0.00370
Gnomad AMR exome
AF:
0.0103
Gnomad ASJ exome
AF:
0.0132
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0439
Gnomad NFE exome
AF:
0.0288
Gnomad OTH exome
AF:
0.0239
GnomAD4 exome
AF:
0.0237
AC:
34598
AN:
1461562
Hom.:
468
Cov.:
33
AF XY:
0.0234
AC XY:
16994
AN XY:
727078
show subpopulations
African (AFR)
AF:
0.00311
AC:
104
AN:
33480
American (AMR)
AF:
0.0110
AC:
492
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
339
AN:
26100
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00651
AC:
561
AN:
86226
European-Finnish (FIN)
AF:
0.0428
AC:
2288
AN:
53402
Middle Eastern (MID)
AF:
0.0154
AC:
89
AN:
5764
European-Non Finnish (NFE)
AF:
0.0266
AC:
29519
AN:
1111822
Other (OTH)
AF:
0.0199
AC:
1204
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1891
3781
5672
7562
9453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1054
2108
3162
4216
5270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0193
AC:
2939
AN:
152330
Hom.:
39
Cov.:
33
AF XY:
0.0196
AC XY:
1461
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00457
AC:
190
AN:
41594
American (AMR)
AF:
0.0204
AC:
313
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4832
European-Finnish (FIN)
AF:
0.0417
AC:
443
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0277
AC:
1884
AN:
68012
Other (OTH)
AF:
0.0175
AC:
37
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
145
290
434
579
724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0246
Hom.:
88
Bravo
AF:
0.0171
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0257
EpiControl
AF:
0.0260

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Developmental and epileptic encephalopathy, 18 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 06, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
15
DANN
Benign
0.64
PhyloP100
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.22
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.22
Position offset: 11

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72671125; hg19: chr1-43905286; API